Atlas Trials

Safety Study of High-Dose Ranibizumab for Polypoidal Choroidal Vasculopathy

Clinical trial NCT01248117 · UNKNOWN

Trial details

NCT number
NCT01248117
Sponsor
Retina Consultants of Hawaii
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Polypoidal Choroidal Vasculopathy
Start date
2010-11-01
Primary completion
2012-12-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.